Synonyms: SPR-719 | VXc-486
Compound class:
Synthetic organic
Comment: SPR719 is a novel aminobenzimidazole antibacterial compound that is a dual Inhibitor of bacterial DNA gyrase and DNA topoisomerase 4 [1]. An orally administered prodrug, fobrepodacin (SPR720), is being developed for the treatment of non-tuberculous mycobacterial pulmonary disease (NTM-PD).
|
|
No information available. |
Summary of Clinical Use ![]() |
The results from a Phase 1 study suggest that predicted therapeutic exposure of SPR719 can be achieved with once-daily oral administration of fobrepodacin (NCT03796910) [3]. |